May 8, 2026 - 02:27

Absci has provided updates on its clinical programs and released its financial results for the first quarter of 2026. The company announced it has successfully dosed all four planned healthy volunteer cohorts in the single ascending dose (SAD) portion of its ongoing ABS-201 HEADLINE trial. The drug, being developed for androgenetic alopecia (AGA), or pattern hair loss, was reported to be well-tolerated with favorable emerging safety data.
Preliminary pharmacokinetic modeling from the HEADLINE trial supports the targeted dosing interval for ABS-201. The company has also initiated dosing for the first multiple ascending dose (MAD) cohort in participants with AGA.
Beyond ABS-201, Absci is expanding its prolactin program by adding ABS-202 to its internal pipeline. The company is headquartered in Vancouver, Washington, and also has operations in New York. The first quarter financial report covers the period ending March 31, 2026.
July 18, 2026 - 06:59
Boston businesses hope energy from World Cup crowds can have lasting impact on nightlifeBoston`s summer of massive international events is winding down, but the energy from the World Cup crowds has local businesses and residents hoping the momentum sticks around long after the final...
July 17, 2026 - 23:34
Nexus unveils first startup school cohort of companiesNexus Louisiana has announced the first group of companies selected for its new Stealthmode Startup School, marking a fresh push to support early-stage ventures in the region. The announcement came...
July 17, 2026 - 00:55
Japanese business culture focus of new study abroad offering at MSUMontana State University has launched a new study abroad initiative centered on Japanese business culture, offering students a unique lens into corporate practices in one of the world`s largest...
July 16, 2026 - 03:02
Google’s Head of Search Shares 3 Rules Every Business Needs to Win in the AI EraGoogle`s Vice President of Search, Liz Reid, recently shared critical advice for entrepreneurs navigating the rapidly shifting landscape of online discovery. In a conversation with Inc., Reid...